Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling hungry on the 25mg Wegovy tablet is more common than people expect, and it doesn't mean the medicine has stopped working. The 25mg dose is the maintenance dose of oral semaglutide, licensed in the UK as Wegovy tablets, and trial data show appetite suppression varies between individuals even at maximum dose. If food feels more appealing than it did at lower doses, there are a few well-understood reasons for that. These are prescription-only medicines; a clinician decides whether the dose or your treatment plan needs adjusting.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phase 3 OASIS 4 trial, which Novo Nordisk cited when the MHRA approved oral semaglutide for weight management in June 2026, enrolled 307 adults with obesity or overweight and at least one weight-related condition. Over 64 weeks, participants taking 25mg oral semaglutide lost around 13.6% of body weight on average compared with about 2.4% on placebo. Among those who adhered fully to the regimen, average loss reached around 16.6%. That gap matters here: it tells you that how consistently you take the tablet, and under the right conditions, influences how much the medicine does.
The trial didn't measure hunger scores as a primary endpoint, but the weight-loss variance across participants points to real differences in how strongly individuals respond at any given dose. Reduced appetite is the mechanism through which semaglutide works, but the reasons hunger persists despite that mechanism are worth understanding before drawing conclusions about whether the dose is right for you.
The NHS medicines page for semaglutide explains that the medicine slows gastric emptying and signals fullness through GLP-1 receptors, effects that are real but that sit on top of your body's own hunger hormones, which don't simply switch off. [NHS: Semaglutide]
There is a misconception worth addressing plainly: many people assume that because 25mg is the highest dose, any remaining hunger must mean the medicine has failed. It usually doesn't. The more likely culprits are practical ones.
Oral semaglutide's absorption depends on tight conditions. The tablet needs to be taken first thing in the morning on an empty stomach, with a small amount of plain water, with at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medicines. Coffee before the 30-minute window closes, a small sip of juice with the tablet, or taking it after a glass of milk, any of these reduce how much semaglutide actually reaches your bloodstream. More detail on how Wegovy works explains the mechanism, but the practical upshot is simple: a tablet taken in imperfect conditions is a lower-dose tablet in effect.
If your 25mg dose is being absorbed well, the appetite effect tends to be most noticeable in the hours after taking the tablet and tapers slightly through the day. Feeling hungrier in the evening is normal and not a sign of treatment failure. What you eat matters too: food choices on Wegovy can meaningfully extend or undermine the satiety effect across a day.
There is a difference between hunger that is manageable and background noise, and hunger that feels indistinguishable from life before treatment. The former is expected. The latter is worth a clinical conversation.
A few things that can blunt semaglutide's appetite effect even at 25mg: chronic sleep deprivation raises ghrelin (a hunger-stimulating hormone) enough to partly override GLP-1 signalling; high stress does something similar via cortisol; diets very low in protein tend to increase hunger on any weight-loss medicine because protein is the most satiating macronutrient. Some people find appetite virtually disappears on this treatment, and others (even at the same dose) find it gentler. Both experiences sit within the trial evidence.
If after a month at 25mg your hunger feels unchanged from baseline, or if hunger has returned after working well at a lower dose, tell your prescriber. They may review your dose timing, assess whether a different treatment suits you better, or simply confirm the treatment is doing what it should at a slower pace. At nume, a GPhC-registered prescriber reviews every repeat order and every clinical query, a real clinician reads your case, not a bot.
For anyone considering starting oral semaglutide or switching from the injection, our guide to managing hunger on Wegovy is worth reading alongside our free consultation, which walks through eligibility and whether Wegovy tablets are the right fit for your situation. Prescription-only medicines deserve that level of review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.